Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials

類似資料

• Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
  著者:: Montgomery, Stuart A., 等
  出版事項: (2014)
• A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
  著者:: Sambunaris, Angelo, 等
  出版事項: (2014)
• Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder
  著者:: Thase, Michael E., 等
  出版事項: (2016)
• The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study
  著者:: Montgomery, Stuart A., 等
  出版事項: (2014)
• A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorder
  著者:: Gommoll, Carl P., 等
  出版事項: (2014)